Speciality: Emergency Medicine
Description:
A warm welcome to all the medical professionals in this interesting session on the potential benefits of intravenous glutamine therapy.
Intravenous (IV) glutamine therapy has garnered attention for its potential therapeutic benefits in various clinical settings. Glutamine, an amino acid, plays a crucial role in numerous physiological processes, including protein synthesis, immune function, and cellular metabolism.
IV administration of glutamine bypasses the digestive system, allowing for rapid absorption and delivery of this essential nutrient directly into the bloodstream. This method is particularly beneficial for patients with conditions such as critical illness, sepsis, and intestinal failure, where oral intake may be compromised or insufficient. IV glutamine supplementation aims to replenish depleted glutamine stores, support immune function, and promote tissue repair and recovery in critically ill patients.
The use of IV glutamine therapy extends beyond critical care settings, with emerging evidence suggesting potential benefits in other clinical scenarios. For example, IV glutamine has shown promise in reducing chemotherapy-induced mucositis and improving outcomes in patients undergoing bone marrow transplantation.
Therefore, get an overall knowledge on the understanding of the potential benefits of intravenous glutamine therapy. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
See More Webinars @ Hidoc Webinars
1.
Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment
2.
A small rise in cancer was observed following the 1986 Chernobyl accident.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
2.
Survivorship Planning Beyond Active Cancer Care
3.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
4.
Integrated Models in Hematology for Specialists
5.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation